Difficulty: Medium
Average Score: 85%
Practice
Gram-negative organisms are largely insensitive to benzyl penicillin because
Correct answer
C
Rationale
In understanding why Gram-negative organisms are largely insensitive to benzyl penicillin, option C is correct because benzyl penicillin struggles to penetrate deeper into the lipoprotein-peptidoglycan multi-layered cell wall of these bacteria. Gram-negative bacteria have an additional outer membrane that acts as a barrier, making it difficult for certain antibiotics, like benzyl penicillin, to effectively target them.
Option A is incorrect because penicillinase is an enzyme that breaks down penicillin, making it ineffective, but this is not the primary reason for the insensitivity of Gram-negative bacteria to benzyl penicillin.
Option B is incorrect because the inhibition of D-alanine incorporation by benzyl penicillin is more relevant to the action of other antibiotics like vancomycin, not specifically benzyl penicillin.
Educationally, this question highlights the importance of understanding the structural differences between Gram-negative and Gram-positive bacteria and how these variances can impact the effectiveness of antibiotics. It underscores the need for targeted antibiotic therapies based on the specific characteristics of different bacterial species to ensure successful treatment outcomes.
Option A is incorrect because penicillinase is an enzyme that breaks down penicillin, making it ineffective, but this is not the primary reason for the insensitivity of Gram-negative bacteria to benzyl penicillin.
Option B is incorrect because the inhibition of D-alanine incorporation by benzyl penicillin is more relevant to the action of other antibiotics like vancomycin, not specifically benzyl penicillin.
Educationally, this question highlights the importance of understanding the structural differences between Gram-negative and Gram-positive bacteria and how these variances can impact the effectiveness of antibiotics. It underscores the need for targeted antibiotic therapies based on the specific characteristics of different bacterial species to ensure successful treatment outcomes.